Cyclacel Pharmaceuticals (CYCC) Posts Wider than Expected Q1 Loss
Cyclacel Pharmaceuticals (NASDAQ: CYCC) reported Q1 loss ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
